INDIVIDUALIZATION OF HIGH-DOSE METHOTREXATE POSOLOGY BY DETERMINATION OF PLASMA-CONCENTRATIONS AND ITS ROLE IN THE TREATMENT OF OSTEOGENIC-SARCOMA

被引：0
|
作者：
DELEPINE, N
DESBOIS, JC
DELEPINE, G
CORNILLE, H
ASTIER, A
ALKALLAF, S
机构：
[1] CLIN PRE GENTIL,UNITE ONCOL ORTHOPED,F-93000 ROSNY BOIS,FRANCE
[2] HOP HENRI MONDOR,SERV TOXICOL,F-94000 CRETEIL,FRANCE
来源：
BULLETIN DU CANCER | 1989年 / 76卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：913 / 918
页数：6
相关论文
共 50 条
  • [21] HIGH-DOSE CISPLATIN TREATMENT - HEARING-LOSS AND PLASMA-CONCENTRATIONS
    LAURELL, G
    JUNGNELIUS, U
    LARYNGOSCOPE, 1990, 100 (07): : 724 - 734
  • [22] TRANSIENT NEUROLOGICAL DISTURBANCES INDUCED BY THE CHEMOTHERAPY OF HIGH-DOSE METHOTREXATE FOR OSTEOGENIC-SARCOMA (VOL 5, PG 480, 1994)
    KIU, MC
    LIAW, CC
    YANG, TS
    LAI, GM
    HSI, SN
    LU, CS
    ANTI-CANCER DRUGS, 1994, 5 (06) : 676 - 676
  • [23] SEQUENTIAL COMBINATION CHEMOTHERAPY (CONTAINING HIGH-DOSE CYCLOPHOSPHAMIDE) FOR METASTATIC OSTEOGENIC-SARCOMA
    LEVINE, AS
    APPELBAUM, FR
    GRAW, RG
    MAGRATH, IT
    PIZZO, PA
    POPLACK, DG
    ZIEGLER, JL
    CANCER TREATMENT REPORTS, 1978, 62 (02): : 247 - 250
  • [24] EVALUATION OF HIGH-DOSE METHOTREXATE (HDMTX) WITH CITROVORUM FACTOR RESCUE (CFR) SINGLE AGENT CHEMOTHERAPY IN OSTEOGENIC-SARCOMA (OSA)
    ROSEN, G
    NIRENBERG, A
    CAPARROS, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 177 - 177
  • [25] WEEKLY HIGH-DOSE METHOTREXATE-CITROVORUM FACTOR IN OSTEOGENIC-SARCOMA - PRE-SURGICAL TREATMENT OF PRIMARY TUMOR AND OF OVERT PULMONARY METASTASES
    JAFFE, N
    FREI, E
    TRAGGIS, D
    WATTS, H
    CANCER, 1977, 39 (01) : 45 - 50
  • [26] FORMATION OF IMMUNE-COMPLEXES AND CHANGES IN THE COMPLEMENT-SYSTEM IN PATIENTS WITH OSTEOGENIC-SARCOMA UNDERGOING HIGH-DOSE METHOTREXATE THERAPY
    KORHOLZ, D
    KORHOLZ, U
    JURGENS, H
    GOBEL, U
    WAHN, V
    KLINISCHE PADIATRIE, 1987, 199 (01): : 22 - 26
  • [27] Pharmacokinetic Individualization of High-Dose Methotrexate Chemotherapy for the Treatment of Localized Osteosarcoma
    Fujita, Y.
    Nakamura, T.
    Aomori, T.
    Nishiba, H.
    Shinozaki, T.
    Yanagawa, T.
    Takagishi, K.
    Watanabe, H.
    Okada, Y.
    Nakamura, K.
    Horiuchi, R.
    Yamamoto, K.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (03) : 186 - 190
  • [28] ANAPHYLACTIC REACTION TO METHOTREXATE USED IN HIGH-DOSES AS AN ADJUVANT TREATMENT OF OSTEOGENIC-SARCOMA
    KLIMO, P
    IBRAHIM, E
    CANCER TREATMENT REPORTS, 1981, 65 (7-8): : 725 - 725
  • [29] HIGH-DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE AND ADRIAMYCIN IN CHILDHOOD OSTEOGENIC SARCOMA
    ROSEN, G
    SUWANSIR.S
    KWON, C
    TAN, C
    WU, SJ
    BEATTIE, EJ
    MURPHY, ML
    CANCER, 1974, 33 (06) : 1151 - 1163
  • [30] Acral erythema caused by high-dose methotrexate therapy in patients with osteogenic sarcoma
    Postovsky, S
    Ben Arush, MW
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2005, 22 (02) : 167 - 173
12345